On November 2, 2004 The Wall Street Journal published an article describing the manner in which Merck’s executives made decisions about Vioxx. The Wall Street Journal article pointed out that the November 2000 issue of The New England Journal of Medicine included an article describing the results of the VIGOR study. The New England Journal of Medicine article stated that Vioxx did not significantly increase the incidence of heart attacks among patients who did not appear to be at high risk of having a heart attack. Notably, Merck had excluded subjects whose risk of experiencing a heart attack was anything but low. In retrospect, the executive editor of The New England Journal, Gregory Curfman, told The Wall Street Journal that his journal did not have all the details that were available to the FDA. He stated that his journal concentrated its efforts on ensuring that the text of the article accurately represented the data presented in the article. The authors of the article were academics who received consulting contracts or research grants from Merck and employees of Merck. Can you detect any behavioral issues and agency conflict issues in the above discussion?
We need at least 10 more requests to produce the solution.
0 / 10 have requested this problem solution
The more requests, the faster the answer.